Company IMAC Holdings, Inc.

Equities

BACK

US44967K3023

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Hospitals, Clinics & Primary Care Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
3.38 ^USD	+7.64%		-0.59%	+52.94%

May. 06	Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	CI
Apr. 16	IMAC Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinsonâs disease. The Company is also engaged in providing the precision medicine business. The Company's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.

Number of employees: 3

Managers	Title	Age	Since
Jeffrey Ervin CEO	Chief Executive Officer	46	15-02-28
Matthew Wallis FOU	Founder	50	00-07-31
Sheri Gardzina DFI	Director of Finance/CFO	55	17-10-31

Members of the board	Title	Age	Since
Michael Pruitt BRD	Director/Board Member	64	20-10-20
Cary Sucoff BRD	Director/Board Member	71	20-10-20
Jeffrey Ervin CEO	Chief Executive Officer	46	15-02-28
Matthew Wallis FOU	Founder	50	00-07-31
Evans Maurice BRD	Director/Board Member	44	20-10-20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,148,321	938,998 ( 81.77 %)	0	81.77 %
Stock B	0	4,550	0	0

Name	Equities	%	Valuation
Matthew Wallis 5.085 %	58,390	5.085 %	297 789 $
Kestra Advisory Services LLC 4.910 %	56,385	4.910 %	287 564 $
Alpha Capital Anstalt 4.744 %	54,482	4.744 %	277 858 $
HRT Financial LLC 4.516 %	51,862	4.516 %	264 496 $
Peter S. Lynch 4.027 %	46,248	4.027 %	235 865 $
Osaic Wealth, Inc. 2.873 %	32,992	2.873 %	168 259 $
Evans Maurice 1.283 %	14,737	1.283 %	75 159 $
Jeffrey Ervin 1.078 %	12,380	1.078 %	63 138 $
Two Sigma Investments LP 0.9909 %	11,379	0.9909 %	58 033 $
Cary Sucoff 0.8708 %	10,000	0.8708 %	51 000 $

IMAC Holdings, Inc.

3401 Mallory Lane Suite 100

37067, Franklin

http://www.imacregeneration.com

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.38 USD

Average target price

8 USD

Spread / Average Target

+136.69%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
IMAC HOLDINGS, INC.	+52.94%	3.61M
AIER EYE HOSPITAL GROUP CO., LTD.	-18.52%	16.2B
BANGKOK DUSIT MEDICAL SERVICES	+5.41%	12.73B
IHH HEALTHCARE	+3.98%	11.68B
APOLLO HOSPITALS ENTERPRISE LIMITED	+4.36%	10.22B
ENCOMPASS HEALTH CORPORATION	+28.07%	8.6B
RAMSAY HEALTH CARE LIMITED	-4.98%	7.78B
THE ENSIGN GROUP, INC.	+6.76%	6.73B
MOUWASAT MEDICAL SERVICES COMPANY	+7.33%	6.4B
GLOBAL HEALTH LIMITED	+48.17%	4.49B

Hospitals, Clinics & Primary Care Services